Tag Archives: Medical/Health Care

Varian Halcyon Systems Expand Access to Cancer Care at Three Centers in Africa

PALO ALTO, California, May 30, 2018 /PRNewswire/ — Designed to expand the availability of high quality cancer care globally and help save the lives of millions more cancer patients, treatments with Varian’s (NYSE: VAR) Halcyon system have started at three different cancer centers in northern and southern Africa. Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity-modulated radiotherapy (IMRT), including improved patient comfort and shortening the time from installation to first treatment without sacrificing quality.

The cancer centers now offering Halcyon treatments in Africa are Clinique le Littoral Casablanca and Centre d’Oncologie Nakhil Rabat in Morocco, and Busamed Oncology Center- Hillcrest in South Africa.

  • Clinique le Littoral Casablanca, Morocco was the first Halcyon installation in Africa and was selected over other available solutions to help address the cancer center’s growing patient volume, and as a complement to their existing capabilities.
  • Centre d’Oncologie Nakhil Rabat, Morocco was able to have the system installed, commissioned, staff trained and begin treating patients in just two weeks. Since beginning Halcyon treatments in January 2018, the center is already providing care to over 70 patients per day on this system as part of their expanding state-of-the-art techniques including IGRT, RapidArc and SBRT using other Varian equipment exclusively.
  • Busamed Oncology Center- Hillcrest, South Africa was the first Halcyon installation in Sub-Sahara Africa. This project is a symbol of a successful collaboration between the oncology center, Varian and partners for responding to the oncology need in the province. The fast installation process, ease of customer training, useful QA tools, and seamless workflows allowed the center to quickly begin offering treatments with the new system.

With the innovations in Halcyon, the system delivers high quality treatments, which empowers clinicians to care for more patients. Halcyon features a streamlined workflow that only requires nine steps from the start to the end of treatment compared to up to more than 30 steps with older technologies. To assist in the reduction of time and construction costs from installation to first patient treatment, Halcyon offers expedited commissioning, requires less shielding than traditional systems, can fit in the majority of existing small vaults and can be installed in two weeks or less. Several cancer centers have already begun treating patients with Halcyon including Radiation Oncology Centres (Australia), University Hospitals Leuven (Belgium), Queen’s Hospital (England), and Penn Medicine (U.S.).

“We are proud of our collaboration with these centers in Africa and increasing the access to high quality cancer treatments with Halcyon,” said Jean-LucDevleeschauwer, president, Varian Oncology Systems EMEIA. “We look forward to working with more centers across the region, and around the world, in the global fight against cancer.”

About Varian
Varian is a leader in developing and delivering cancer care solutions, and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Press Contact

Mark Plungy
Director, Public Relations
+1 (650) 424-5630
mark.plungy@varian.com

Investor Relations Contact

J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com

Leading Bed Net Manufacturer, Vestergaard, Meets WHO’s Approval For PBO Long-Lasting Insecticidal Nets With PermaNet® 3.0, A Next Generation Bednet

Advanced technology offers increased efficacy against mosquitoes resistant to the insecticide currently approved for use in bed nets LAUSANNE, Switzerland, April 25, 2018 /PRNewswire/ — Vestergaard, the leading manufacturer of Long Lasting Insecticidal Nets (LLINS) to prevent malaria, celebrates PermaNet® 3.0 following the World Health Organization’s (WHO’s) approval of a new class of LLINs, called PBO […] read more

World’s Leading Health Organizations Release Third Edition of Widely Used Resource on Family Planning

Global Handbook Gives Health-Care Providers Accurate and Practical Guidance for Counseling Clients NEW DELHI, Feb. 13, 2018 /PRNewswire/ — Family planning is considered a development “best buy” and a life-saving intervention for millions of women and girls. Crucial to the success of family planning efforts worldwide is a well-educated and trained health workforce. In support of […] read more

Les principaux organismes de santé du monde publient la troisième édition d’une ressource largement utilisée en matière de planification familiale

Un guide mondial à l’intention des prestataires de soins de santé fournissant des conseils précis et pratiques pour le conseil des clients NEW DELHI, 13 février 2018 /PRNewswire/ — La planification familiale est considérée comme un « excellent choix » en matière de développement et une intervention vitale pour des millions de femmes et de filles. Pour que […] read more

Treatments Commence at Two Algerian Hospitals Equipped with Modern Varian Radiotherapy Systems

ALGIERS, Algeria, Nov. 6, 2017 /PRNewswire/ — Cancer patients in Algeria now have access to modern radiotherapy care with the commencement of treatments at two of six public hospitals currently being equipped by Varian (NYSE: VAR), the world leader in radiotherapy equipment and software. Treatments delivered using linear accelerators including Algeria’s first TrueBeam™ systems are […] read more

L.E.A.F. Pharmaceuticals Establishes its First Subsidiary in Rwanda

L.E.A.F. Rwanda Ltd. to focus on establishing Kigali as a biotechnology hub in Africa VALLEY FORGE, Pennsylvania, Aug. 16, 2017 /PRNewswire/ — L.E.A.F. Pharmaceuticals LLC, a global pharmaceutical company located in the historic area of Valley Forge, Pennsylvania, USA, with a mission to discover, develop and commercialize innovative and safe therapies for cancer, today announced the […] read more

Collaborative Global Effort to Advance Blood Safety Moves Forward Across Ghana

LAKEWOOD, Colorado, May 11, 2017 /PRNewswire/ — Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, announced today the implementation of the Mirasol® Pathogen Reduction Technology (PRT) System for Whole Blood (WB) in Accra and Kumasi, Ghana. The Mirasol PRT system for WB will be used in conjunction with a hemovigilance […] read more

Korea International Cooperation Agency (KOICA) Honored for Pioneering Global Health Work with First-ever Golisano Global Health Leadership Award

Honoree Announced at Special Olympics World Winter Games in Austria SCHLADMING, Austria, March 20, 2017 /PRNewswire/ — The Golisano Foundation and Special Olympics, the largest public health organization for people with intellectual disabilities (ID), honored the Korea International Cooperation Agency (KOICA) for their work with Special Olympics Uganda in creating health solutions where there is no […] read more

Meridian Malaria Test Wins Prestigious Innovation Award

illumigene® Malaria Receives 1st Place Award at the Journées Internationales de Biologie /Association des Colloques Nationaux des Biologistes Conference in Paris CINCINNATI, Aug. 30, 2016 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ:VIVO) was awarded 1st place for innovation in emergency treatment and point-of-care testing for its illumigene® Malaria test at the 2016 JIB/ACNBH Conference this summer. […] read more